메뉴 건너뛰기

이너포스

공지사항

    • 글자 크기

Proxy Advisors ISS, Glass Lewis Recommend Re-election Of BP Leadership

Cristine180813367024924 시간 전조회 수 0댓글 0

Climate-focused investors decry strategy revamp

*

Activist investor Elliott also dissatisfied

*

Glass Lewis expects BP to improve disclosure

(Adds Glass Lewis comment)

By Shadia Nasralla

LONDON, March 26 (Reuters) - Proxy advisors Institutional Shareholder Services Inc (ISS) and Glass Lewis recommend that shareholders vote in favour of the re-election of BP's board and management at the April 17 annual general meeting, according documents seen by Reuters.

BP stock has underperformed rivals Shell and Cheap Private Proxies Exxon in the last five years, which investors have blamed in part on the company's 2020 plan to focus on growing its renewable business while cutting oil and gas production.

Having watered down that plan, BP accelerated its pivot back to hydrocarbons in a strategy revamp last month.

Activist shareholder Elliott Management, which has a near 5% stake in BP, has met several BP shareholders to try to forge a consensus for more changes at the oil major that could include cost cuts and a potential leadership reshuffle, two shareholders have told Reuters.

Another BP activist investor, Follow This, has called for a vote against Chair Helge Lund, claiming he should have offered investors a say on scrapping energy transition targets, a view echoed by other climate-focused shareholders.

"While some shareholders may have wished for an opportunity to vote on the Company's climate plans given substantial revisions, the decision not to present such a vote does not, in ISS's view, constitute a material failure of governance," ISS said.

Glass Lewis said in its recommendation document that "while we have some concerns surrounding the transparency of the decision not to present the updated climate strategy for a shareholder vote, we do not consider it appropriate for shareholders to vote against the re-election of director Lund on this basis at this time."

"We will, however, continue to monitor this issue, and expect the Company to improve its disclosure regarding its engagement on these matters going forward." (Reporting by Shadia Nasralla; Editing by Jan Harvey, Tomasz Janowski and David Evans)
  • 0
  • 0
    • 글자 크기
Cristine1808133670249 (비회원)

댓글 달기 WYSIWYG 사용

댓글 쓰기 권한이 없습니다.
정렬

검색

번호 제목 글쓴이 날짜 조회 수
38860 Signs And Symptoms And Causes StanSanders874485 2025.04.05 3
38859 Causes And Signs NadiaLynton5351774 2025.04.05 0
38858 Contrast Of Erectile Dysfunction Treatments BarbaraRivett545348 2025.04.05 0
38857 Contrast Of Erectile Dysfunction Treatments ClintJoseph46287 2025.04.05 0
38856 Contrast Of Impotence Treatments ClementWhish64538169 2025.04.05 3
38855 Equity Mortgage Release DanielaGariepy87781 2025.04.05 0
38854 13 Great Questions To Ask Your Equity Release Advisor FawnVarghese522 2025.04.05 2
38853 Contrast Of Erectile Dysfunction Treatments LeoProwse0023059 2025.04.05 0
38852 Viagra, Cialis, Levitra, Stendra MaxwellEdmiston264 2025.04.05 0
38851 Contrast Of Impotence Treatments WinnieImlay32759619 2025.04.05 2
38850 Kinds, Cost, And More RalfMontemayor0 2025.04.05 2
38849 Types, Cost, And Much More GenaStorkey95196 2025.04.05 2
38848 Pension Income Calculator MichalSheehy494 2025.04.05 2
38847 Kinds, Price, And Much More Roland1268245842 2025.04.05 2
38846 Diagnosis And Treatment WinnieImlay32759619 2025.04.05 2
38845 Diagnosis And Therapy JoshBligh421405 2025.04.05 2
38844 Kinds, Price, And Extra TyreeDelvalle4632802 2025.04.05 2
38843 Contrast Of Erectile Dysfunction Treatments ClintJoseph46287 2025.04.05 0
38842 Viagra And Other Oral Medicines GenaStorkey95196 2025.04.05 0
38841 Viagra, Cialis, Levitra, Stendra KurtCarmody42108 2025.04.05 0
정렬

검색

위로